Evaluating the cost-effectiveness of [ 18 F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients.

Michelle TewAbby P DouglasJeff SzerAshish BajelSimon J HarrisonShio Yen TioLeon J WorthRodney J HicksDavid RitchieMonica A SlavinKarin A ThurskyKim Dalziel

Published in: Cancer imaging : the official publication of the International Cancer Imaging Society (2023)

This trial is registered with ClinicalTrials.gov, NCT03429387.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
clinical trial
peritoneal dialysis
prognostic factors
randomized controlled trial
phase iii
patient reported outcomes
patient reported
open label